A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake

Toxicology and Applied Pharmacology

Volumn 152, Issue 1, 1998, Pages 276-281

  McCarver, D Gail ^a   Byun, Ray ^a   Hines, Ronald N ^a   Hichme, Michilene ^a   Wegenek, Wendee ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHLORZOXAZONE; CYTOCHROME P450 2E1; LIVER ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG HYDROXYLATION; ENZYME INDUCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC REGULATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; OBESITY; REGULATOR GENE; STRUCTURE ACTIVITY RELATION;

EID: 0031737607     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8532     Document Type: Article

References (40)

1. Ankenbauer, W., Strahle, U., and Schutz, G. (1988). Synergistic action of glucocorticoid and estradiol responsive elements. Proc. Natl. Acad. Sci. USA 85, 7526-7530.
2. Badger, T. M., Huang, J., Ronis, M., and Lumpkin, C. K. (1993). Induction of cytochrome P450 2E1 during chronic ethanol exposure occurs via transcription of the CYP 2E1 gene when blood alcohol concentrations are high. Biochem. Biophys. Res. Commun. 190, 780-785.
3. Boutelet-Bochan, H., Huang, Y., and Juchau, M. R. (1997). Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: Implications for the fetal alcohol syndrome. Biochem. Biophys. Res. Commun. 238, 443-447.
4. Bowman, R. S., Stein, L. I., and Newton, J. R. (1975). Measurement and interpretation of drinking behavior. J. Stud. Alcohol 36, 1154-1172.
5. Carpenter, S. P., Lasker, J. M., and Raucy, J. L. (1996). Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol. Pharmacol. 49, 260-268.
6. Carr, L. G., Hartleroad, J. Y., Liang, Y., Mendenhall, C., Moritz, T., and Thomasson, H. (1995). Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol. Clin. Exp. Res. 19, 182-184.
7. Carr, L. G., Yi, I. S., Li, T. K., and Yin, S. J. (1996). Cytochrome P4502E1 genotypes, alcoholism, and alcoholic cirrhosis in Han Chinese and Atayal natives of Taiwan. Alcohol. Clin. Exp. Res. 20, 43-46.
8. Carriere, V., Berthou, F., Baird, S., Belloc, C., Beaune, P., and de, W., I (1996). Human cytochrome P450 2E1 (CYP2E1): From genotype to phenotype. Pharmacogenetics 6, 203-211.
9. Cohen, G., Sinet, P. M., and Heikkila, R. (1980). Ethanol oxidation by rat brain in vivo. Alcohol. Clin. Exp. Res. 4, 366-370.
10. Girre, C., Lucas, D., Hispard, E., Menez, C., Dally, S., and Menez, J.-F. (1994). Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. 47, 1503-1508.
11. Hayashi, S., Watanabe, J., and Kawajiri, K. (1991). Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 110, 559-565.
12. Hu, Y., Oscarson, M., Johansson, I., Yue, Q. Y., Dahl, M. L., Tabone, M., Arinco, S., Albano, E., and Ingelman-Sundberg, M. (1997). Genetic polymorphism of human CYP2E1: Characterization of two variant alleles. Mol. Pharmacol. 51, 370-376.
13. In, K. H., Asano, K., Beier, D., Grobholz, J., Finn, P. W., Silverman, E. K., Silverman, E. S., Collins, T., Fischer, A. R., Keith, T. P., Serino, K., Kim, S. W., De Sanctis, G. T., Yandava, C., Pillari, A., Rubin, P., Kemp, J., Israel, E., Busse, W., Ledford, D., Murray, J. J., Segal, A., Tinkleman, D., and Drazen, J. M. (1997). Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99, 1130-1137.
14. Jantzen, H. M., Strahle, U., Gloss, B., Stewart, F., Schmid, W., Boshart, M., Miksicek, R., and Schutz, G. (1987). Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49, 29-38.
15. Kato, S., Shields, P. G., Caporaso, N. E., Houver, R., Trump, B. F., Sugimura, H., Weston, A., and Harris, C. C. (1992). Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 52, 6712-6715.
16. Kelsell, D. P., Wolf, C. R., and Spurr, N. K. (1990). An Xmnl RFLP detected with a probe for the CYP2E gene locus on chromosome 10. Nucleic Acids Res. 18, 3111.
17. Kim, R. B., O'Shea, D., and Wilkinson, G. R. (1995). Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin. Pharmacol. Ther. 57, 645-655.
18. Kim, R. B., Yamazaki, H., Chiba, K., O'Shea, D., Mimura, M., Guengerich, F. P., Ishizaki, T., Shimada, T., and Wilkinson, G. R. (1996). In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J. Pharmacol. Exp. Ther. 279, 4-11.
19. Lieber, C. S. (1997). Cytochrome P-4502e1: Its physiological and pathological role. Physiol. Rev. 77, 517-544.
20. O'Shea, D., Davis, S. N., Kim, R. B., and Wilkinson, G. R. (1994). Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clin. Pharmacol. Ther. 56, 359-367.
21. Pearson, M. A., Hoyme, H. E., Saver, L. H., and Rimsza, M. E. (1994). Toluene embryopathy: Delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 93, 211-215.
22. Persson, I., Johansson, I., Barging, H., Dahl, M. L., Sideward, J., Rylander, R., Rannug, A., Hogberg, J., and Ingelman-Sundberg, M. (1993). Genetic polymorphism of cytochrome P4502E1 in a Swedish population; Relationship to incidence of lung cancer. FEBS Lett. 319, 207-211.
23. Peter, R., Bocker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C. S. (1990). Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem. Res. Toxicol. 3, 566-573.
24. Pirmohamed, M., Kitteringham, N. R., Quest, L. J., Allott, R. L., Green, V. J., Gilmore, I. T., and Park, B. K. (1995). Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics 5, 351-357.
25. Raskin, N. H., and Sokoloff, L. (1970). Alcohol dehydrogenase in rat brain and liver. J. Neurochem. 17, 1677-1687.
26. Reynolds, J. D., and Brien, J. F. (1995). Ethanol neurobehavioural teratogenesis and the role of L-glutamate in the fetal hippocampus. Can. J. Physiol. Pharmacol. 73, 1209-1223.
27. Roberts, B. J., Song, B. J., Soh, Y., Park, S. S., and Shoaf, S. E. (1995). Ethanol induces CYP2E1 by protein stabilization - Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J. Biol. Chem. 270, 29632-29635.
28. Salazar, D. E., Sorge, C. L., and Corcoran, G. B. (1988). Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat. Biochem. Biophys. Res. Commun. 157, 315-320.
29. Schule, R., Muller, M., Otsuka-Murakami, H., and Renkawitz, R. (1988). Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature 332, 87-90.
30. Shoda, T., Shimizu, M., Kamimura, S., and Okumura, M. (1993). Immuno-histochemical demonstration of ethanol-inducible P450 2E1 in rat brain. Alcohol Alcohol. 28, 69-75.
31. Sokol, R., Ager, J., Martier, S., Debanne, S., Ernhart, C., Kuzma, J., and Miller, S. I. (1986). Significant determinants of susceptibility to alcohol teratogenicity. Ann. NY Acad. Sci. 477, 87-102.
32. Song, B. J. (1996). Ethanol-inducible cytochrome P450 (CYP2E1): Biochemistry, molecular biology and clinical relevance: 1996 update. Alcohol. Clin. Exp. Res. 20, 138A-146A.
33. Tassaneeyakul, W., Birkett, D. J., Edwards, J. W., Veronese, M. E., Tukey, R. H., and Miners, J. O. (1996). Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. J. Pharmacol. Exp. Ther. 276, 101-108.
34. Tsutsumi, M., Lasker, J. M., Takahashi, T., and Lieber, C. S. (1993). In vivo induction of hepatic P4502E1 by ethanol: Role of increased enzyme synthesis. Arch. Biochem. Biophys. 304, 209-218.
35. Uematsu, F., Kikuchi, H., Ohmachi, T., Sagami, I., Motomiya, M., Kamataki, T., Komori, M., and Watanabe, M. (1991). Two common RFLPs of the human CYP2E gene. Nucleic Acids Res. 18, 2803.
36. Ueno, Y., Adachi, J., Imamichi, H., Nishimura, A., and Tatsuno, Y. (1996). Effect of the cytochrome P-450IIE1 genotype on ethanol elimination rate in alcoholics and control subjects. Alcohol. Clin. Exp. Res. 20, 17A-21A.
37. Umeno, M., McBride, O. W., Yang, C. S., Gelboin, H. V., and Gonzalez, F. J. (1988). Human ethanol-inducible P450IIE1: Complete gene sequence, promoter characterization, chromosome mapping and cDNA-directed expression. Biochemistry 27, 9006-9013.
38. Wrighton, S. A., Thomas, P. E., Molowa, D. T., Haniu, M., Shively, J. E., Maines, S. L., Watkins, P. B., Parker, G., Mendez-Picon, G., Levin, W., and Guzelian, P. S. (1986). Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry 25, 6731-6735.
39. Yoo, J.-S. H., Ning, S. M., Pantuck, C. B., Pantuck, E. J., and Yang, C. S. (1991). Regulation of hepatic microsomal cytochrome P450IIE1 level by dietary lipid and carbohydrates in rats. J. Nutr. 121, 959-965.
40. Yun, Y. P., Casazza, J. P., Sohn, D. H., Veech, R. L., and Song, B. J. (1992). Pretranslational activation of cytochrome P450IIE1 during ketosis induced by a high fat diet. Mol. Pharmacol. 41, 474-479.